{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:44:50Z","timestamp":1782251090551,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00108-009-2419-6","type":"journal-article","created":{"date-parts":[[2009,12,14]],"date-time":"2009-12-14T16:37:32Z","timestamp":1260808652000},"page":"21-29","source":"Crossref","is-referenced-by-count":11,"title":["Pathophysiologie der Leberfibrose","Liver fibrosis \u2013 Pathogenesis and novel therapeutic approaches"],"prefix":"10.1007","volume":"51","author":[{"given":"F.","family":"Tacke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Weiskirchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,23]]},"reference":[{"key":"2419_CR1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-230X-3-29","volume":"3","author":"Arias","year":"2003","unstructured":"Arias M, Sauer-Lehnen S, Treptau J et al. (2003) Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol 3: 29","journal-title":"BMC Gastroenterol"},{"key":"2419_CR2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.gastro.2007.10.024","volume":"134","author":"Baumeister","year":"2008","unstructured":"Baumeister SE, Volzke H, Marschall P et al. (2008) Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation. Gastroenterology 134: 85\u201394","journal-title":"Gastroenterology"},{"key":"2419_CR3","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/labinvest.3700094","volume":"84","author":"Borkham-Kamphorst","year":"2004","unstructured":"Borkham-Kamphorst E, Herrmann J, Stoll D et al. (2004) Dominant-negative soluble PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis. Lab Invest 84: 766\u2013777","journal-title":"Lab Invest"},{"key":"2419_CR4","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.bbrc.2005.10.139","volume":"338","author":"Borkham-Kamphorst","year":"2005","unstructured":"Borkham-Kamphorst E, Meurer SK, Gressner AM, Weiskirchen R (2005) Disruption of intermolecular disulfide bonds in PDGF-BB dimers by N-acetyl-L-cysteine does not prevent PDGF signaling in cultured hepatic stellate cells. Biochem Biophys Res Commun 338: 1711\u20131718","journal-title":"Biochem Biophys Res Commun"},{"key":"2419_CR5","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jhep.2007.01.029","volume":"46","author":"Borkham-Kamphorst","year":"2007","unstructured":"Borkham-Kamphorst E, van Roeyen CR, Ostendorf T et al. (2007) Pro-fibrogenic potential of PDGF-D in liver fibrosis. J Hepatol 46: 1064\u20131074","journal-title":"J Hepatol"},{"key":"2419_CR6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0016-5085(03)00666-8","volume":"125","author":"Dooley","year":"2003","unstructured":"Dooley S, Hamzavi J, Breitkopf K et al. (2003) Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125: 178\u2013191","journal-title":"Gastroenterology"},{"key":"2419_CR7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI200522675","volume":"115","author":"Duffield","year":"2005","unstructured":"Duffield JS, Forbes SJ, Constandinou CM et al. (2005) Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115: 56\u201365","journal-title":"J Clin Invest"},{"key":"2419_CR8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"Friedman","year":"2008","unstructured":"Friedman SL (2008) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125\u2013172","journal-title":"Physiol Rev"},{"key":"2419_CR9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2009.01.068","volume":"137","author":"Giebeler","year":"2009","unstructured":"Giebeler A, Boekschoten MV, Klein C et al. (2009) c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice. Gastroenterology 137: 297\u2013308","journal-title":"Gastroenterology"},{"key":"2419_CR10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","volume":"10","author":"Gressner","year":"2006","unstructured":"Gressner AM, Weiskirchen R (2006) Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 10: 76\u201399","journal-title":"J Cell Mol Med"},{"key":"2419_CR11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/187152809789352230","volume":"8","author":"Heymann","year":"2009","unstructured":"Heymann F, Trautwein C, Tacke F (2009) Monocytes and macrophages as cellular targets in liver fibrosis. Inflamm Allergy Drug Targets 8: 307\u2013318","journal-title":"Inflamm Allergy Drug Targets"},{"key":"2419_CR12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrd2734","volume":"8","author":"Horuk","year":"2009","unstructured":"Horuk R (2009) Chemokine receptor antagonists: overcoming developmental hurdles. Nat Rev Drug Discov 8: 23\u201333","journal-title":"Nat Rev Drug Discov"},{"key":"2419_CR13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","volume":"117","author":"Iredale","year":"2007","unstructured":"Iredale JP (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117: 539\u2013548","journal-title":"J Clin Invest"},{"key":"2419_CR14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1586\/17474124.2.2.233","volume":"2","author":"Karlmark","year":"2008","unstructured":"Karlmark KR, Wasmuth HE, Trautwein C, Tacke F (2008) Chemokine-directed immune cell infiltration in acute and chronic liver disease. Expert Rev Gastroenterol Hepatol 2: 233\u2013242","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2419_CR15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.22950","volume":"50","author":"Karlmark","year":"2009","unstructured":"Karlmark KR, Weiskirchen R, Zimmermann HW et al. (2009) Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50: 261\u2013274","journal-title":"Hepatology"},{"key":"2419_CR16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/gut.2006.092460","volume":"56","author":"Kinoshita","year":"2007","unstructured":"Kinoshita K, Iimuro Y, Otogawa K et al. (2007) Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut 56: 706\u2013714","journal-title":"Gut"},{"key":"2419_CR17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbrc.2006.11.029","volume":"352","author":"Kordes","year":"2007","unstructured":"Kordes C, Sawitza I, Muller-Marbach A et al. (2007) CD133+ hepatic stellate cells are progenitor cells. Biochem Biophys Res Commun 352: 410\u2013417","journal-title":"Biochem Biophys Res Commun"},{"key":"2419_CR18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bcp.2005.07.001","volume":"70","author":"Meurer","year":"2005","unstructured":"Meurer SK, Lahme B, Tihaa L et al. (2005) N-acetyl-L-cysteine suppresses TGF-beta signaling at distinct molecular steps: the biochemical and biological efficacy of a multifunctional, antifibrotic drug. Biochem Pharmacol 70: 1026\u20131034","journal-title":"Biochem Pharmacol"},{"key":"2419_CR19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/hep.21561","volume":"45","author":"Pockros","year":"2007","unstructured":"Pockros PJ, Jeffers L, Afdhal N et al. (2007) Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis. Hepatology 45: 569\u2013578","journal-title":"Hepatology"},{"key":"2419_CR20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1055\/s-2001-17551","volume":"21","author":"Rockey","year":"2001","unstructured":"Rockey DC (2001) Hepatic blood flow regulation by stellate cells in normal and injured liver. Semin Liver Dis 21: 337\u2013349","journal-title":"Semin Liver Dis"},{"key":"2419_CR21","first-page":"1858","volume":"119","author":"Seki","year":"2009","unstructured":"Seki E, De Minicis S, Gwak GY et al. (2009) CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest 119: 1858\u20131870","journal-title":"J Clin Invest"},{"key":"2419_CR22","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"Seki","year":"2007","unstructured":"Seki E, De Minicis S, Osterreicher CH et al. (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 13: 1324\u20131332","journal-title":"Nat Med"},{"key":"2419_CR23","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1055\/s-0029-1233994","volume":"134","author":"Tacke","year":"2009","unstructured":"Tacke F (2009) Monozyten-Subpopulationen in Entz\u00fcndungsprozessen: Prinzip und Perspektive. Dtsch Med Wochenschr 134: 1645\u20131648","journal-title":"Dtsch Med Wochenschr"},{"key":"2419_CR24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI28549","volume":"117","author":"Tacke","year":"2007","unstructured":"Tacke F, Alvarez D, Kaplan TJ et al. (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117: 185\u2013194","journal-title":"J Clin Invest"},{"key":"2419_CR25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.imbio.2006.05.025","volume":"211","author":"Tacke","year":"2006","unstructured":"Tacke F, Randolph GJ (2006) Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211: 609\u2013618","journal-title":"Immunobiology"},{"key":"2419_CR26","first-page":"87","volume":"128","author":"Trautwein","year":"2003","unstructured":"Trautwein C, Tacke F (2003) Therapie der Hepatitis-B- und -C-Virusinfektion. Dtsch Med Wochenschr 128: 87\u201389","journal-title":"Dtsch Med Wochenschr"},{"key":"2419_CR27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.gastro.2009.03.053","volume":"137","author":"Wasmuth","year":"2009","unstructured":"Wasmuth HE, Lammert F, Zaldivar MM et al. (2009) Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans. Gastroenterology 137: 309\u2013319","journal-title":"Gastroenterology"},{"key":"2419_CR28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2006-927387","volume":"45","author":"Weiler-Normann","year":"2007","unstructured":"Weiler-Normann C, Herkel J, Lohse AW (2007) Mouse models of liver fibrosis. Z Gastroenterol 45: 43\u201350","journal-title":"Z Gastroenterol"},{"key":"2419_CR29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.immuni.2006.11.011","volume":"26","author":"Winau","year":"2007","unstructured":"Winau F, Hegasy G, Weiskirchen R et al. (2007) Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26: 117\u2013129","journal-title":"Immunity"},{"key":"2419_CR30","doi-asserted-by":"crossref","first-page":"23337","DOI":"10.1074\/jbc.M700194200","volume":"282","author":"Zeisberg","year":"2007","unstructured":"Zeisberg M, Yang C, Martino M et al. (2007) Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282: 23337\u201323347","journal-title":"J Biol Chem"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-009-2419-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-009-2419-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-009-2419-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:12:14Z","timestamp":1558584734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-009-2419-6"}},"subtitle":["Aktuelle Aspekte und neue Ans\u00e4tze f\u00fcr antifibrotische Therapien"],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["2419"],"URL":"https:\/\/doi.org\/10.1007\/s00108-009-2419-6","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}